MeSH tree: C01.925.928
Vaccines are safe and effective, and help reduce death and illness. But global vaccination rates are suboptimal and have trended downward, leaving humanity more vulnerable to vaccine-preventable diseases such as COVID-19, ...
Aug 1, 2024
0
46
Merkel cell carcinoma is a rare but highly aggressive form of skin cancer known for its rapid growth and tendency to metastasize. Despite the promise of immune checkpoint blockade therapy, which can boost the body's immune ...
Jul 26, 2024
0
62
An international research team has demonstrated a method to identify the cells in the immune system that can recognize and fight cancer cells in samples from 9 out of 10 patients affected by the rare but aggressive form of ...
Jul 1, 2024
0
59
A new study that followed a cohort of more than 110,000 people establishes significant disparities in the risk of anal cancer for people with HIV and for men who have sex with men with HIV, depending on the region of the ...
May 7, 2024
0
84
In a first-of-its-kind clinical trial, researchers found that intravenous therapies made from virus-specific T-cells (VST) can effectively treat immunocompromised pediatric patients, far surpassing the current standard of ...
Apr 18, 2024
0
41
Throat cancer is one of the fastest-growing cancers, and it is often linked to HPV. Oropharyngeal cancer, or throat cancer, is a type of head and neck cancer that can be divided into two subgroups: HPV-associated cancers ...
Apr 10, 2024
0
53
A new research review presented at a pre-congress day for this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024, Barcelona, 27-30 April) will look at how to manage the rise in sexually ...
Mar 27, 2024
0
55
In a groundbreaking study, a team led by Würzburg Professor José Pedro Friedmann Angeli has shown that the cholesterol precursor 7-dehydrocholesterol (7-DHC) plays a crucial role as an antioxidant: it integrates into the ...
Jan 31, 2024
0
41
No cervical cancer cases have been detected in fully vaccinated women following the human papillomavirus (HPV) immunization at age 12 to 13, in the 16 years since the program started in Scotland, research has found.
Jan 23, 2024
0
41
Programmed cell death 1 (PD-1) is an important target for immune checkpoint inhibitor therapies that block its signaling and boost T-cell activity. PD-1 inhibitors have been approved for treating various types of cancer.
Jan 20, 2024
0
71
